01 1GLAXO GRP ENGLAND
02 3GLAXOSMITHKLINE
01 48201556
01 4Blank
01 4Y
01 42029-02-05
Patent Expiration Date : 2029-02-05
US Patent Number : 8201556
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205625
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-05
Patent Expiration Date : 2029-02-05
US Patent Number : 8201556
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205625
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-05
Patent Expiration Date : 2029-02-05
US Patent Number : 8201556
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205382
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-05
Patent Expiration Date : 2029-02-05
US Patent Number : 8201556
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205625
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-05
